Skip to main content

Spectrum: Autism Research News

Author

Angie Voyles Askham

News Writer

Angie Voyles Askham is a reporter for Spectrum, where she covers neural circuits and gene therapy, among other topics. She proposed and writes Spectrum Launch, a monthly newsletter for early-career researchers. Before joining Spectrum in 2020, she worked in radio journalism and academic publishing. Voyles Askham has a Ph.D. in neuroscience from NYU and a bachelor’s degree in neuroscience from Vanderbilt University. You can email her at [email protected] or find her on Twitter @avaskham.

Contact Info

[email protected]

September 2022
Week of AugustAug
29th
2022

Spotted around the web: Klinefelter syndrome, REM sleep, mixed-gender research teams

by ,  /  2 September 2022

Here is a roundup of news and research for the week of 29 August.

Comments
August 2022

Promising preclinical results prompt Angelman therapy trial

by  /  25 August 2022

Roche’s gene therapy drug Rugonersen boosts expression of the protein missing in the syndrome in mice and monkeys, but whether it works in people remains to be seen.

Comments
A large MRI scan of a human brain, with a grid of 15 smaller MRI scans to its left

Chromosome 22 mutations leave telltale marks on brain development in autistic people

by  /  24 August 2022

Many brain regions develop differently between people with 22q11.2 duplications and deletions, and those trajectories also vary with a person’s diagnosis.

Comments
Several strands of DNA with different openings at different points to show different functions for the same gene at different points in time

‘Double duty’ autism-linked genes upend conventional characterizations

by  /  23 August 2022

What these genes do and how they affect autism depends on when in development they’re studied, despite what classic ‘gene ontology’ analyses say.

Comments
Week of AugustAug
15th
2022

Spotted around the web: Antidepressants, PAX5 mutations, preprints

by ,  /  19 August 2022

Here is a roundup of news and research for the week of 15 August.

Comments
Week of AugustAug
8th
2022

Spotted around the web: Neuroscience tools, cerebellar enhancers, private equity

by , ,  /  12 August 2022

Here is a roundup of news and research for the week of 8 August.

Comments
An Ultragenyx employee removes materials from a lab freezer.

Angelman therapy appears safer in restarted trial

by  /  5 August 2022

Interim results from the previously paused trial suggest that doses of the experimental gene therapy drug GTX-102 are well tolerated in children with the autism-linked condition.

Comments
Illustration shows a road going into the distance, seen from the driver's point of view.

Spectrum Launch: How to break down biases in neuroscience

by  /  4 August 2022

Through a website called Stories of Women in Neuroscience, Nancy Padilla-Coreano aims to shift biases in the field, one conversation at a time.

Comments

Of mice and human interneurons: A Q&A with Moritz Helmstaedter

by  /  1 August 2022

People’s brains have a larger network of inhibitory interneurons than mouse brains do, according to a new study. Changes to that network could contribute to autism or other conditions, says lead investigator Moritz Helmstaedter.

Comments
July 2022
Concept illustration of DNA deletion: 2 DNA strands extend horizontally across a burnt orange background. The bottom is intact, while there are gaps in the top strand.

Deletions on chromosome 22 have ripple effects across genome

by  /  20 July 2022

Deletion of the 22q11.2 chromosomal region alters the expression of numerous autism- and schizophrenia-linked genes, most of which are not contained within the deleted region, a new study suggests.

Comments